Pharmacare would save thousands for Alberta families: CUPE
CALGARY, Alberta--(BUSINESS WIRE)-- At a time of record inflation, it’s ‘beyond absurd’ that Alberta would opt out of a national pharmacare program that would save families thousands of dollars in prescription fees. CUPE Alberta President Rory Gill called on Alberta Premier Danielle Smith to reverse her position and offer financial relief to the province.
“It’s absurd to me that someone in Ontario or Quebec would be able to access a prescription plan, but Albertans would have to pay out of pocket for private insurance, if they can get it at all,” said Gill. “A national plan would save everyone money, and it would save lives.”
According to Angus Reid, 21% of Albertans experience cost related barriers in getting the medications they need. That doesn’t factor in others who manage the expense of a private plan but would save money with a national system.
Gill said opting out would hurt efforts to recruit and retain workers, especially in the health care sector, as workers would opt for provinces where they and the people they care for are part of a better healthcare plan.
“Health care providers care about things like drug plans,” said Gill. “We already have a shortage of health care workers; we don’t need to add to the problem.”
View source version on businesswire.com: https://www.businesswire.com/news/home/20240226247765/en/
Lou Arab
Communications Representative
780.271.2722
Source: CUPE
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AULUMU Brings Award-Winning High-Performance Gear to IFA 2026 in Berlin
- ENA Respiratory Awarded Biointelect Venturer Funding to Support New Study in Asthma Patients of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections
- Media Advisory - Marsh and Resilience launch Cyber Protect in Asia to help organizations strengthen cyber resilience
Create E-mail Alert Related Categories
Business Wire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share